Vanguard Personalized Indexing Management, LLC Nuvalent, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 3,802 shares of NUVL stock, worth $309,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,802Holding current value
$309,520% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVL
# of Institutions
216Shares Held
60.9MCall Options Held
319KPut Options Held
211K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.46 Billion32.3% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$429 Million19.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$361 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$246 Million0.01% of portfolio
-
Commodore Capital LP New York, NY1.86MShares$151 Million12.88% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.5B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...